rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2009-11-26
|
pubmed:abstractText |
Genetic predisposition of nuclear factor-kappa B (NF-kappaB)-signaling pathways linking inflammation to hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) remains unresolved. We conducted a case-control study to determine the associations of the polymorphisms within the promoter regions of NFKB1 encoding NF-kappaB1 and NFKBIA encoding IkappaBalpha with the development of HCC. A total of 404 healthy controls, 482 non-HCC subjects with HBV infection and 202 patients with HCC were included. NFKB1 -94ATTG2 allele and GG allele in the 3'-untranslated region of NFKBIA were more prevalent in HCC patients than in the healthy controls. NFKBIA -826CT and NFKBIA -881AG allelic carriages were more prevalent in HCC patients than in the non-HCC subjects with HBV infection. The estimated haplotype frequency of NFKBIA promoter -881G-826T-519C was significantly higher in the patients with HCC than in the HBV-infected subjects without HCC (odds ratio = 3.142, P = 0.002). As compared with the HBV-infected subjects without HCC, NFKBIA -826 T and NFKBIA -881AG allelic carriages were only associated with HCC risk in the subjects with HBV genotype C. The association of NFKBIA -881AG allelic carriage with HCC risk was not affected by liver cirrhosis (LC) status, alanine aminotransferase level and hepatitis B e antigen status. By multivariate regression analysis, NFKB1 -94ATTG2, NFKBIA -826T, NFKBIA -881AG and HBV genotype C were independently associated with an increased risk of HCC. In conclusion, NFKB1 -94ATTG2 allele and haplotype -881G-826T-519C in NFKBIA promoter were associated with hepatocarcinogenesis. NFKBIA -826T and -881AG were associated with the risk of HCC in the subjects infected with HBV genotype C.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-10454581,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-11147598,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-11185536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-12124405,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-12406554,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-12613200,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-12640529,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-12944982,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-14613970,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-14961554,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-15090469,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-15329734,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-15713961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-15785084,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-16391218,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-16540234,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-16724054,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17050029,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17224304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17354114,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17492467,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17570226,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17661407,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-17999990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-18192693,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-18390844,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-18600435,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19223558,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19231580,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19250206,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19321801,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19381306,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19446741,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-19574418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-8918553,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19797428-9299585
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1460-2180
|
pubmed:author |
pubmed-author:CaoGuangwenG,
pubmed-author:HeYongchaoY,
pubmed-author:LiChengzhongC,
pubmed-author:LiuShijianS,
pubmed-author:TanXiaojieX,
pubmed-author:WangHongyangH,
pubmed-author:XieJiaxinJ,
pubmed-author:YinJianhuaJ,
pubmed-author:ZhangHongweiH,
pubmed-author:ZhangQianQ,
pubmed-author:ZhaoJunJ
|
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1916-22
|
pubmed:dateRevised |
2010-9-28
|
pubmed:meshHeading |
pubmed-meshheading:19797428-Adult,
pubmed-meshheading:19797428-Alleles,
pubmed-meshheading:19797428-Carcinoma, Hepatocellular,
pubmed-meshheading:19797428-Case-Control Studies,
pubmed-meshheading:19797428-Female,
pubmed-meshheading:19797428-Genetic Predisposition to Disease,
pubmed-meshheading:19797428-Haplotypes,
pubmed-meshheading:19797428-Hepatitis B,
pubmed-meshheading:19797428-Hepatitis B e Antigens,
pubmed-meshheading:19797428-Hepatitis B virus,
pubmed-meshheading:19797428-Humans,
pubmed-meshheading:19797428-I-kappa B Proteins,
pubmed-meshheading:19797428-Liver Cirrhosis,
pubmed-meshheading:19797428-Liver Neoplasms,
pubmed-meshheading:19797428-Male,
pubmed-meshheading:19797428-Middle Aged,
pubmed-meshheading:19797428-NF-kappa B p50 Subunit,
pubmed-meshheading:19797428-Odds Ratio,
pubmed-meshheading:19797428-Polymorphism, Genetic,
pubmed-meshheading:19797428-Promoter Regions, Genetic
|
pubmed:year |
2009
|
pubmed:articleTitle |
IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
|
pubmed:affiliation |
Department of Epidemiology, the 1st Affiliated Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China.
|